About this Device
SURGICEL Powder contains 3 grams of Oxidized Regenerated Cellulose (ORC) powder prefilled in an applicator to dispense on a target bleeding site. SURGICEL is bactericidal due to low pH characteristics against a wide range of pathogenic microorganisms. SURGICEL Powder can also be applied in laparoscopic or other endoscopic procedures when used with the SURGICEL™ Endoscopic Applicator.
Economic Evidence
SURGICEL Powder Absorbable Hemostat has economic advantages over ARISTA™ AH.
In a propensity score–matched, retrospective review comparing SURGICEL Powder to ARISTA™ AH in C-section and open hysterectomy cases, SURGICEL Powder was associated with:
• $2,340 lower hospital cost per discharge in C-section casesD6
• $1,955 lower hospital cost per discharge in open hysterectomy casesE6
• Shorter length of stay in C-section casesF6
Adjunctive Hemostat Evidence
Using adjunctive hemostats has been shown to control bleeding effectively and reduce resource use and costs.7-14
• Blood Transfusions—8%-35% fewer patients transfused
• Length of Stay— reduced by 1 to 4.4 days
• Operating Theatre Time— reduced by 15.2 to 25 minutes
• Readmissions— significant reduction within 30 days (8.6% vs. 10.5%; P<0.00)
Features & Benefits
Strong, Durable Clot
SURGICEL Powder achieved hemostasis on 15 out of 15 sites in a diffuse bleeding liver abrasion model while ARISTA™ AH achieved hemostasis on only 4 out of 15.G15

Kills Most Common Bacteria
SURGICEL Powder is proven bactericidal in vitro against more than 2 dozen microbial organisms, including antibiotic-resistant bacteria (MRSA, VRE, PRSP, and MRSE).C5
Ease of Use
Ready to use - right out of the package.5 Designed for one-handed use and consistent dosage per application,16 SURGICEL Powder aims to maximize efficiency - alongside a flexible tip for use on both open and endoscopic applicators.
Device Specifications and Comparisons
Device Specifications and Comparisons
SURGICEL™ Powder (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective.5
Select Competitive Products: BD ARISTA™ AH
Featured Product |
||
![]() |
![]() |
|
SURGICEL™ Powder Absorbable Hemostat |
SURGICEL™ Original Absorbable Hemostat |
|
---|---|---|
Codes |
3013SP, 3123SPEA
|
1955, 1951, 1953, 1952
|
Description |
Fast and durable for broad surface oozing bleeding |
Loose knit ORC fabric |
Indication |
SURGICEL Powder (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective. |
SURGICEL Absorbable Hemostat (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective. |
Size |
3.0g |
|
Absorption Time |
7-14 days |
7-14 days |
Storage Requirements |
Store at controlled room temperature 59º-86ºF (15º-30ºC) |
Store at controlled room temperature 59º-86ºF (15º-30ºC) |
Preparation Time |
Ready out of package |
Ready out of package |
Shelf Life |
18 months |
5 years |
Material/Composition |
Oxidized Regenerated Cellulose with bactericidal properties |
Oxidized Regenerated Cellulose with bactericidal properties |
Mechanism of Action |
Penetrates to the source of bleeding and provides a matrix for platelet adhesion and aggregation |
Provides a matrix for platelet adhesion and aggregation |
Distributor Code |
63713-3013SP |
|
Qty./Box |
5 |
24 |
Supporting Documentation
Clinical Evidence
-
SURGICEL™ Powder GYN Evidence Brief
View PDF
-
SURGICEL™ Powder Orthopedic Brochure
View PDF
-
Select all documents (2)
Product Resources
© Ethicon US, LLC. 2022.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
This site is published by Ethicon US, LLC, which is solely responsible for its contents, and is intended for U.S. audiences only.
This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
Last updated February 20, 2019. The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.